Inclusion Criteria:~* Diagnosis of probable AD according to the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorder Association (NINCDS-ADRDA)
criteria~* Mini-Mental State Examination (MMSE) score of 18-26 points at screening~* Geriatric Depression Scale
(GDS-15) score of < 6~* Completion of 6 years of education (or good work history consistent with exclusion of
mental retardation or other pervasive developmental disorders)~* If receiving concurrent AD treatment, patient
must be on the medication for at least 3 months at a stable dose for at least 2 months prior to randomization.~
